EUVIMEDEUVIMED entdecken
Crossref

Salvianolic acid B improves the microcirculation in a mouse model of sepsis through a mechanism involving the platelet receptor CD226

Xuemei Li, Shanshou Liu, Jiangang Xie, Lin Liu, Chujun Duan, Lu Yang, Yuling Wang, Yilin Wu, Niqi Shan, Yun Zhang, Yuan Zhang, Ran Zhuang

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.17371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Xuemei Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Fourth Military Medical University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Benzofurans, Blood Platelets, Disease Models, Animal, Mice, Inbred C57BL. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Boost Program of Xijing Hospital, National Natural Science Foundation of China, Natural Science Foundation Project in Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Salvianolic acid B (SalB) demonstrates diverse clinical applications, particularly in cardiovascular and cerebral protection. This study primarily investigated the effects of SalB on sepsis. Experimental Approach The model of sepsis via caecal ligation puncture (CLP) was established in male C57BL/6 mice. Therapeutic effects of SalB on hepatic and pulmonary injury, inflammatory responses and microcirculatory disturbances in sepsis were evaluated. Platelet aggregation and adhesion were measured via flow cytometry and an adhesion test. After overexpression of platelet‐related activating molecules by 293T cells, the efficient binding of SalB and platelet CD226 molecules was further evaluated. Finally, neutralizing antibody experiments were used to assess the mechanism of SalB in alleviating the progression of sepsis. Key Results SalB mitigated hepatic and pulmonary impairments, reduced inflammatory cytokine levels and enhanced mesenteric microvascular blood flow in septic mice. SalB enhanced CLP‐induced reduction of platelet count and platelet pressure cumulative volume. SalB reduced platelet adhesion to endothelial cells and platelet aggregation to leukocytes. A high binding efficiency was observed between SalB and the platelet adhesion molecule CD226. Ex vivo, interactions between SalB and platelets from CD226‐knockout mice were markedly decreased. In vivo administration of CD226 neutralizing antibodies significantly delayed disease progression and enhanced mesenteric microcirculation in septic mice. Conclusion and Implications In our murine model of sepsis, treatment with SalB improved the microcirculatory disturbance and hindered the progression of sepsis by inhibiting platelet CD226 function. Our results suggest SalB is a promising therapeutic approach to the treatment of sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzofuransBlood PlateletsDisease Models, AnimalMice, Inbred C57BLMicrocirculationSepsisAnimalsHumansMaleMiceAntigens, Differentiation, T-LymphocyteMice, KnockoutPlatelet AdhesivenessPlatelet AggregationT Lineage-Specific Activation Antigen 1Depsides

Stichwörter der Autor:innen

adhesion moleculemicrocirculatory dysfunctionplateletsalvianolic acid Bsepsis

Substanzen

Antigens, Differentiation, T-LymphocyteBenzofuranssalvianolic acid BT Lineage-Specific Activation Antigen 1Depsides

Autor:innen und Institutionen

  • Department of Immunology, Fourth Military Medical University, Xi'an, Shaanxi, China.
  • College of Life Sciences, Northwest University, Xi'an, Shaanxi, China.
  • Department of Emergency, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
  • Institute of Medical Research, Northwestern Polytechnical University, Xi'an, Shaanxi, China.

Förderung

  • Boost Program of Xijing Hospital
  • National Natural Science Foundation of China
  • Natural Science Foundation Project in Shaanxi Province
  • Innovation Foundation for Doctor Dissertation of Northwestern Polytechnical University

Zitieren

APA

Li, X., Liu, S., Xie, J., Liu, L., Duan, C., Yang, L., Wang, Y., Wu, Y., Shan, N., Zhang, Y., Zhang, Y., & Zhuang, R. (2025). Salvianolic acid B improves the microcirculation in a mouse model of sepsis through a mechanism involving the platelet receptor CD226. British Journal of Pharmacology. https://doi.org/10.1111/bph.17371

Vancouver

Li X, Liu S, Xie J, Liu L, Duan C, Yang L, et al. Salvianolic acid B improves the microcirculation in a mouse model of sepsis through a mechanism involving the platelet receptor CD226. British Journal of Pharmacology. 2025. doi:10.1111/bph.17371

BibTeX
@article{Li2025,
  author = {Li, Xuemei and Liu, Shanshou and Xie, Jiangang and Liu, Lin and Duan, Chujun and Yang, Lu and Wang, Yuling and Wu, Yilin and Shan, Niqi and Zhang, Yun and Zhang, Yuan and Zhuang, Ran},
  title = {Salvianolic acid B improves the microcirculation in a mouse model of sepsis through a mechanism involving the platelet receptor CD226},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.17371}
}
Kostenlos starten →